Catherine Stevenson Email & Phone Number

Reston, VA, US

Lawrence Township, NJ, US

Cambridge, Massachusetts, US

• Led oncology new product planning including commercial analysis spanning TPPs, forecasting, NPVs, market research, value propositions, and path to market.
• Generated business cases in partnership with BD for 3 assets, including one full due diligence.
• Developed business case and competitive positioning analysis for Ph1 cell therapy product, resulting in a change to success criteria.
• Designed framework for supporting early-stage R&D, inputting into indication selection for 3 potential new programs.
• Streamlined commercial intelligence function to actively track, analyze and prioritize key industry insights.

Emeryville, CA, US

• Led New Product Planning team, providing strategic direction for 6 products moving through preclinical and early-stage development.
• Collaborated with marketing and medical affairs to design product re-launch post new CDC recommendation, including HCP and DTC strategy.
• Created product strategy group across 6 functions to establish TPPs and business plans that enable strategic investment decisions.
• Led commercial pipeline input including competitor assessment, US/EU5/ROW forecasts, NPV models, and market research.
• Generated business cases in partnership with BD to assess over 10 opportunities, leading to 2 full due diligences.
• Led assessment of non-vaccine products for inorganic growth, identifying 2 M&A opportunities.

Emeryville, CA, US

• Led policy and market shaping activities to support Hep-B market growth leading to CDC recommendation that doubled target addressable market.
• Co-led KOL engagements and advisory boards to create market development plan for new HepB recommendation.
• Piloted and led cross-functional pipeline assessment process, leading to addition of 2 preclinical and 1 clinical program.
• Commercial lead for portfolio prioritization process, evaluating commercial opportunities and risks for all products.
• Supported BD assessments leading to 2 new deals supporting preclinical programs.

Emeryville, CA, US

• Drove all aspects of 2022 German HepB vaccine launch from assessment to partner identification to deal negotiation and launch.
• Collaborate closely with the marketing team to align market access channel strategies with overall brand strategy.
• Partnered with R&D project teams on commercial direction for pipeline planning including analysis of 3 potential assets.
• Developed and trained field team on six excel-based value models to support HepB value proposition, supporting product switches and generating evidence to support reimbursement and formulary decisions.

San Francisco, California, US

• Developed pre-launch global value dossier for gene therapy product launching in US and EU.
• Developed TPP and early commercial plan for allogeneic stem-cell therapy.
• Created hemophilia commercial analytics solution in excel to provide metrics including pricing, market share, and payer mix.

• Led Medicare value-based analysis project, producing final recommendations and new training for sales team
• Developed EU5 market access strategy for launch of a respiratory product., engaging with KOLs on HEOR study design, endpoints and RWE generation.
• Developed early commercial plan for gene therapy product to inform market opportunity and TPP.
• Improved pre-launch evidence generation plan for a respiratory product focusing on quality-of-life endpoints.

Brentford, Middlesex, GB

• Cross-functionally developed brand level strategy for market access and pricing in respiratory and antibiotics.
• Designed pricing pilot studies in Kenya increasing respiratory revenue by 15% over 3 quarters.
• Created pricing and market access training programs for sales leaders, leading to 12% increased contact hours with HCPs.

Brentford, Middlesex, GB

• Selected as a high-potential future leader for graduate rotation program with a focus on health outcomes and market access.
• Rotation as a field-based Health Outcomes Liaison for respiratory products.
• Created customer-facing tool to track sales and budget impact utilized in multiple account conversions.
• Led inclusion of health outcomes endpoints in HIV clinical trials, strengthening evidence generation plans.
• Launch team member for specialty asthma product, leading successful UK HTA reimbursement application.

Washington, DC, US

Rockville, Maryland, US

Msc, Science And Health Policy

Bachelor Of Science With Distinction In Research, Microbiology And Immunology